Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alaris Releases 2025 Fourth Quarter Financial Results
-
Canacol Energy Closes First Subsequent Advance Under DIP Financing
-
COVID mRNA Vaccines May Alter Gene Expression, according to Journal of American Physicians and Surgeons
-
Clearway Energy, Inc. Seeks Shareholder Approval at Annual Meeting to Simplify Public Share Class Structure
-
Vislio Launches Exciting New Online Casino Games and Welcomes New Users with Limited-Time 10 VCoin Bonus
-
Midnight Sun Files Technical Report for Kazhiba Main Copper Oxide Project
-
Royale and the PWHL Empower The Next Generation of Athletes with Her Signature Moment
-
Cronus Capital Announces Start of SMB Investment Strategy Focused on Underserved Small and Mid-Sized Firms
-
Allied Gold Announces Filing and Mailing of Management Information Circular in Connection with the Proposed Arrangement with Zijin Gold International
-
Swiss Water Conference Call Notification for 2025 Fourth Quarter Results
-
LGI Homes Returns to Seagoville, TX, with the Grand Opening of Edmonds Ranch
-
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
-
MAX Power Adopts Shareholder Rights Plan
-
Diversified Energy Announces Secondary Offering of Common Stock
-
Iris Acquisition Corp II Signs Letter of Intent for a Business Combination to form Freedom Metals Corporation – A U.S. Strategic Antimony & Tungsten Platform
-
Manasquan Bank’s James S. Vaccaro Appointed President of National Community Depository Institutions Advisory Council (CDIAC)
-
South Plains Financial, Inc. Publishes 2025 Community Impact Report
-
USA Rare Earth Expands Leadership Team Following Landmark Agreement with U.S. Government
-
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
-
Hallador Energy Appoints Power Industry Veteran Daniel Hudson to Board of Directors and Elevates Heath Lovell to Chief Operating Officer
-
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
-
Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
-
Xos Announces Production Rollout of Vehicle-to-Grid Capability Across Its Full Commercial Electric Vehicle and Energy Solutions Portfolio
-
Cal-Maine Foods Schedules Third Quarter Fiscal 2026 Earnings Release, Conference Call and Webcast
-
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
-
Dynagas LNG Partners LP Announces Date for the Release of the Fourth Quarter and Year Ended 2025 Results
-
NL REPORTS FOURTH QUARTER 2025 RESULTS
-
The Right to Religious Exemption to Vaccination Upheld in Court, according to the Journal of American Physicians and Surgeons
-
FreightCar America, Inc. Reports Fourth Quarter and Full Year 2025 Results
-
Onity® Group to Rebrand PHH Mortgage to Onity® Mortgage
-
Microchip Technology to Present at the Cantor Global Technology & Industrial Growth Conference
-
Fluent Announces Unaudited Fourth Quarter and Full-Year 2025 Financial Results; Commerce Media Solutions Revenue Run Rate Exceeds $105 Million and Represents 56% of Consolidated Enterprise Revenue
-
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
-
Global Ship Lease Declares Quarterly Dividend on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares
-
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
-
Greenlight Re Announces Financial Results for Fourth Quarter and Year-End December 31, 2025
-
KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2025 RESULTS
-
Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend
-
SBA Bans Foreign Nationals from Accessing SBA-backed Loans
-
LifeMD Reports Fourth Quarter and Full Year 2025 Results
-
Canterbury Park Holding Corporation Reports 2025 Fourth Quarter Results
-
Oxford to Release Fourth Quarter Fiscal 2025 Results on March 26, 2026
-
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
-
AEON Biopharma Appoints John Bencich as Chief Financial Officer
-
CapsoVision to Participate in the 38th Annual ROTH Conference
-
Asure Hosting Fireside Chat on Its Latest Perspective on Artificial Intelligence
-
Amplify Energy Announces Strategic Initiatives Update, Year-End 2025 Proved Reserves, Fourth Quarter and Full Year 2025 Results, and 2026 Development Plans and Guidance
-
StepStone Group Announces $100 Million Stock Repurchase Program
-
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results
